Biomarkers in Cancer

Association of MTHFR (C677T) Gene Polymorphism With Breast Cancer in North India

Submit a Paper

Biomarkers in Cancer 2016:8 111-117

Original Research

Published on 27 Sep 2016

DOI: 10.4137/BIC.S40446

Further metadata provided in PDF

Sign up for email alerts to receive notifications of new articles published in Biomarkers in Cancer


Background: Breast cancer is one of the most common malignancies in women and is associated with a variety of risk factors. The functional single-nucleotide polymorphism (SNP) C677T in the gene encoding 5,10-methylenetetrahydrofolate reductase (MTHFR) may lead to decreased enzyme activity and affect the chemosensitivity of tumor cells. This study was designed to investigate the association of MTHFR gene polymorphism (SNP) in the pathogenesis of breast cancer among the North Indian women population.

Materials and Methods: Genotyping was performed by polymerase chain reaction (PCR) using genomic DNA, extracted from the peripheral blood of subjects with (275 cases) or without (275 controls) breast cancer. Restriction fragment length polymorphism was used to study C677T polymorphism in the study groups.

Results: The distribution of MTHFR (C677T) genotype frequencies, ie, CC, TT, and CT, among the patients was 64.7%, 2.18%, and 33.09%, respectively. In the healthy control group, the CC, TT, and CT frequencies were 78.91%, 1.09%, and 20.1%, respectively. The frequencies of C and T alleles were 81.2% and 18.7%, respectively, in the patient subjects, while they were 88.9% and 11.09%, respectively, among the healthy control group. Frequencies of the CT genotype and the T allele were significantly different (P = 0.007 and P = 0.005, respectively) between the control and the case subjects.

Conclusion: This study shows an association of the CT genotype and the T allele of the MTHFR (C667T) gene with increased genetic risk for breast cancer among Indian women.




BibTex citation   (BIBDESK, LATEX)


What Your Colleagues Say About Biomarkers in Cancer
I had a great experience in publishing a review article in Biomarkers in Cancer.  The submission process was extremely smooth and peer review was fast and channelized.  At each and every step I was able to monitor the progress.  Response to my communication was instant and every time confirmation emails were sent.  The publication processing team provided excellent support for proof reading and corrections.  I recommend publishing in it and wish them success. ...
Dr Ranjit Chauhan (University of Winnipeg, Winnipeg, MB, Canada)
More Testimonials

Quick Links

New article and journal news notification services